SCHEMBL7665285

SCHEMBL7665285

Cc1sccc1N(S(=O)(=O)c1ccccc1)S(=O)(=O)c1ccccc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.45
CYP3A4 P08684 1/20 0.43
CYP2C9 P11712 1/20 0.43
CYP2C19 P33261 1/20 0.43
APOBEC3G Q9HC16 1/20 0.41
HSD11B1 P28845 1/20 0.41
KMT2A Q03164 3/20 0.39
NPSR1 Q6W5P4 2/20 0.39
MEN1 O00255 2/20 0.39
KDM4E B2RXH2 2/20 0.39
C5AR1 P21730 1/20 0.39
GBA1 P04062 2/20 0.38
LMNA P02545 1/20 0.38
HPGD P15428 1/20 0.38
TSHR P16473 1/20 0.38
MAPK1 P28482 1/20 0.38
MAPK10 P53779 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
HSD17B10 Q99714 1/20 0.38
CA12 O43570 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3655683 0.77 RORC (0.46) ALDH1A1CYP3A4CYP2C9CYP2C19NPSR1
SCHEMBL13744464 0.77 NR1I2 (0.39) ALDH1A1CYP3A4CYP2C19KMT2ANPSR1
SCHEMBL5853978 0.74 TEAD1 (0.49) ALDH1A1CYP3A4CYP2C9CYP2C19APOBEC3G
SCHEMBL16539957 0.69 APOBEC3G (0.45) ALDH1A1CYP3A4CYP2C9CYP2C19APOBEC3G
SCHEMBL7241182 0.68 HTR2A (0.41) ALDH1A1CYP3A4CYP2C9CYP2C19KMT2A
SCHEMBL7243222 0.68 C5AR1 (0.41) ALDH1A1KMT2AMEN1KDM4EC5AR1
SCHEMBL7240812 0.67 C1S (0.48) ALDH1A1CYP3A4CYP2C9CYP2C19
SCHEMBL16550141 0.67 APOBEC3G (0.52) ALDH1A1CYP3A4CYP2C9CYP2C19APOBEC3G
SCHEMBL10788022 0.67 PTPRC (0.59) ALDH1A1KMT2ANPSR1C5AR1LMNA
SCHEMBL5853971 0.67 CYP3A4 (0.47) ALDH1A1CYP3A4CYP2C9CYP2C19APOBEC3G

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6492403-B1 TREATING SYMPTOMS OF ACUTE OR CHRONIC DISORDER MEDIATED BY CLASSICAL PATHWAY OF COMPLEMENT CASCADE; PROTEASE INHIBITORS 3-DIMENSIONAL PHARMACEUTICALS, INC. 2002-12-10 US disclosed